Jessica Kurten has to explain drug in horse’s system to FEI

Irish show jumper Jessica Kurten has until Monday, 12 November, to explain how a banned drug entered her horse’s system.

Random blood samples were taken from Jessica’s horse Castle Forbes Maike at La Baule, France, in May. Tests on two samples have since returned positive for a non-steroidal anti-inflammatory drug called Etoricoxib.

While not widely known for its use in horses, Etoricoxib is classed as a “medication” substance rather than a “doping” substance.

As such, the presence of Etoricoxib in the horse’s blood is a minor infringement of the rules set out by the governing body of horse sport, the International Equestrian Federation (FEI).

“It’s absolutely standard procedure,” said a spokesman for the FEI, who added: “She requested a longer deadline, but we set it to 12 November. We are doing our best not to drag it on forever.”

If Jessica Kurten accepted liability, she could pay a CHF750 (£320) fine and forfeit the €22,000 (£15,400) she won at the show.

But the show jumper insists her horse was not given any drug, and has said she wants the case heard in front of an FEI tribunal. Jessica has also publicly accused the FEI of bungling the case.

Jessica Kurten has until 12 November to explain how the drug could have possibly entered Castle Forbes Maike’s system, after which a date will be set for her tribunal.

Stay in touch with all the news in the run-up to and throughout the major shows and events during 2026 and beyond with a Horse & Hound subscription. Subscribe today for all you need to know ahead of these major events, plus online reports on the action as it happens from our expert team of reporters and in-depth analysis in our special commemorative magazines. Have a subscription already? Set up your unlimited website access now